Growth hormone tested to flush out hidden HIV
NCT ID NCT03091374
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 30 times
Summary
This study tested whether giving recombinant human growth hormone for 48 weeks could reduce the hidden HIV reservoir in people already on successful antiretroviral therapy (ART). 22 adults with undetectable viral loads and healthy immune systems took part. The goal was to see if the hormone could help the body control the virus without lifelong medication, but the study primarily measured changes in the size of the viral reservoir.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mcgill University Health Center
Montreal, Quebec, H4A 3J1, Canada
Conditions
Explore the condition pages connected to this study.